New England Research & Management, Inc. Catalent, Inc. Transaction History

New England Research & Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 09, 2019	SELL	$39.26 - $54.21 $302,302 - $417,417	-7,700 Closed	0 $0
Q1 2019 Apr 03, 2019	SELL	$29.84 - $43.92 $13,428 - $19,764	-450 Reduced 5.52%	7,700 $313,000
Q4 2018 Jan 11, 2019	BUY	$29.95 - $46.34 $244,092 - $377,671	8,150 New	8,150 $254,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.